Back to search

Article

Cardiovascular Disease (CVD) Risk Assessment of HIV Medication Regimens using hematopoietic CD34+ progenitor cells

2022-01-12

Abstract excerpt

<title>Abstract</title> <p>Background To determine the effects of integrase inhibitor (INSTI) in comparison to non INSTI based regimens such as non-nucleoside reverse transcriptase inhibitors (NNRTIs) based regimens on cardiovascular disease (CVD) risk in HIV+ patients without overt history of CVD or diabetes, with normal CD4:CD8 count. For CVD risk assessment we primarily used hematopoietic CD34+ progenitor cell...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
affbc381-b26b-5ba3-830a-c7296f7ffcb5
DOI
10.21203/rs.3.rs-1226890/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Cardiovascular Disease (CVD) Risk Assessment of HIV Medication Regimens using hematopoietic CD34+ progenitor cellsDOI 10.21203/rs.3.rs-1226890/v1
Telmisartan increases vascular reparative capacity in older HIV-infected adults: a pilot study.Semantic proximity
Epigenetics, HIV, and Cardiovascular Disease Risk.Semantic proximity
Systemic inflammation and risk of age-associated diseases in people living with HIV on long term suppressive antiretroviral therapySemantic proximity
HIV-associated nephropathy in African Americans11The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. The publisher or recipient acknowledges right of the U.S. Government to retain a nonexclusive, royalty-free license in and to any copyright covering the article.Semantic proximity
An updated prediction model of the global risk of cardiovascular disease in HIV-positive persons: The Data-collection on Adverse Effects of Anti-HIV Drugs (D:A:D) study.Semantic proximity
Interaction of Antiretroviral Drugs with the Microbiome &amp; Implications on the development of cardiovascular diseases in HIV+ persons: A Study ProtocolSemantic proximity
Alterations in Circulating T-Cell Subsets with Gut-Homing/Residency Phenotypes Predict HIV-1 Status and Subclinical AtherosclerosisSemantic proximity
Factors Associated with Prognostic or Treatment Outcomes in HIV/AIDS Patients with and without Hypertension in EswatiniSemantic proximity
Short Communication High Risk of Endothelial Dysfunction in HIV Individuals May Result from Deregulation of Circulating Endothelial Cells and Endothelial Progenitor CellsSemantic proximity
Clonal Hematopoiesis and Major Adverse Cardiac Events in People With HIV: Insights From the REPRIEVE Trial.Semantic proximity
Genome-wide association study of cardiovascular disease in people with HIV from the Million Veteran Program (MVP).Semantic proximity
Refining biomarker-based clustering of cardiovascular inflammatory phenotypes in HIV using Recursive Feature Addition: A comparative evaluation approach.Semantic proximity
Select a neighboring publication to make it the new centre.